PDA

View Full Version : Head of Adaptive Immunology


Greg Bernhardt
Sep2-08, 11:15 PM
The Company: Our client is a successful and rapidly growing R&D organisation, whose goal is to become a world leader in treatments for serious and life-threatening infections. Its highly productive research activities have led to the discovery of several innovative and potent antiviral agents. It already has two products on the market and several in advanced clinical development.
The Company also aims to establish a leadership position in host antiviral response therapeutics and prophylaxis….



More... (http://www.nature.com/naturejobs/science/jobs/68746)